The growing concern is financing past phase 2... The theory is a higher price with Aspire's 25 million will pay the costs... Well, we've seen dilution "much smaller scale" drop this from the .60's back to the .15's... a rebound since to .23 is a disgrace and shows minimal indication of B succeeding.